Mali Zeevi
Director of Finance/CFO at BIOLINERX LTD.
Net worth: 15 497 $ as of 29/04/2024
Network origin in Mali Zeevi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 34 | |
Tescom Software Systems Testing Ltd.
 Tescom Software Systems Testing Ltd. Information Technology ServicesTechnology Services Tescom Software Systems Testing Ltd planning and execution of projects in the field of software quality assurance, optimization and improvement of processes in IT organizations in a wide range of companies and fields, such as communications, finance and insurance, commerce and industry, high-tech, government, army and security and the pharmaceutical market. The company was founded in 1990 by Ofer Albeck and is headquartered in Givat Savyon, Israel.
5
| Extinct | Information Technology Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mali Zeevi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Director/Board Member Director/Board Member Chief Operating Officer | |
| SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member Director/Board Member | |
| EVOGENE LTD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| COMPUGEN LTD. | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| Bioline Innovations Jerusalem LP | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | ||
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| MY SIZE, INC. | Internet Software/Services | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman Director/Board Member | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Ben-Gurion University of the Negev | College/University | Doctorate Degree Masters Business Admin | |
| York University | College/University | Undergraduate Degree Masters Business Admin | |
Dreamed Diabetes Ltd.
 Dreamed Diabetes Ltd. Packaged SoftwareTechnology Services DreaMed Diabetes Ltd. is a medical technology company based in Petach Tikva, Israel. DreaMed Diabetes is currently commercializing its endo.digital AI-based clinical decision support system for diabetes management. The endo.digital platform has FDA clearance for patients with type 1 diabetes using continuous glucose monitors or self-monitoring blood glucose monitor devices and insulin pumps. The technology also received expanded FDA clearance to include patients with type 1 or type 2 diabetes on multiple daily injections. The Israeli company's first product, an artificial pancreas technology, was licensed to Medtronic and incorporated into its 780g insulin pump technology. The company provides personalized diabetes treatment optimization solutions and was founded in 2014 by Revital Nimri, Tadej Battelino, Eran Atlas, Thomas Danne, and Ido Muller. Eran Atlas has been the CEO since 2014. | Packaged Software | Director/Board Member Director/Board Member | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Graduate Degree | |
| PURPLE BIOTECH LTD | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Chairman Chairman | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Chairman Director/Board Member | |
Brightman Almagor Zohar & Co.
 Brightman Almagor Zohar & Co. Miscellaneous Commercial ServicesCommercial Services Brightman Almagor Zohar & Co. provides auditing and accounting services to technology, media, telecommunication, real estate, and financial services sectors. The company offers budget control and cost accounting; business planning; transfer pricing; real estate taxation; and audit committee services. The company is headquartered in Tel Aviv, Israel. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Director/Board Member | |
| Fairfield University | College/University | Undergraduate Degree | |
QD Solar, Inc.
 QD Solar, Inc. SemiconductorsElectronic Technology QD Solar, Inc. develops photovoltaic cells using colloidal quantum dot technology in Canada. Its quantum dot technology combines silicon solar cells with infrared solar cells in a hybrid architecture to harvest more of the solar spectrum than silicon alone. The company was founded by Sjoerd Hoogland and Edward Hartley Sargent in 2014 and is headquartered in Toronto, Canada. | Semiconductors | Director/Board Member | |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Bedside Clinical Systems, Inc.
 Bedside Clinical Systems, Inc. Packaged SoftwareTechnology Services Bedside Clinical Systems, Inc. develops Responses to Illness Severity Quantification (RISQ) framework severity of illness clinical decision support for frontline healthcare professionals, hospital administrators and quality managers. It provides BedsidePEWS, that uses the RISQ framework to empower frontline clinicians who care for hospitalized children. The company was founded by Christopher Parshuram in March 2011 and is headquartered in Toronto, Canada. | Packaged Software | Director/Board Member | |
Harbour Antibodies BV
 Harbour Antibodies BV Medical/Nursing ServicesHealth Services Harbour Antibodies BV engages in the production of antibodies and VH domains for therapy. The firm develops two types of human immunoglobulin gene transgenic mice such as mice that generate conventional tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). The company was founded by Frank Grosveld in 2006 and is headquartered in Rotterdam, the Netherlands. | Medical/Nursing Services | Chief Executive Officer | |
| International Genetic Science Partnership | Corporate Officer/Principal | ||
Institute For Pediatric Innovation, Inc.
 Institute For Pediatric Innovation, Inc. Medical/Nursing ServicesHealth Services Institute For Pediatric Innovation, Inc. provides healthcare services. The non-profit company is based in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
Fibrocor Therapeutics LP
 Fibrocor Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety. | Miscellaneous Commercial Services | Chairman | |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Chairman | |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BioJerusalem
 BioJerusalem Financial ConglomeratesFinance BioJerusalem engages in the provision of financial assistance to life sciences companies choosing to launch operations in Jerusalem, which are eligible for prime financial support incentives and are given special preference. The company is headquartered in Jerusalem, Israel. | Financial Conglomerates | Corporate Officer/Principal | |
| NUTRITIONAL GROWTH SOLUTIONS LTD. | Pharmaceuticals: Other | Director/Board Member | |
ImmPACT-Bio Ltd.
 ImmPACT-Bio Ltd. BiotechnologyHealth Technology ImmPACT-Bio Ltd. develops therapies to treat cancer. Its chimeric antigen receptor T-cell (CAR-T) therapy addresses the need to differentiate cancerous from non-cancerous tissues. The company was founded by Gideon Gross in April 2017 and is headquartered in Nes Ziona, Israel. | Biotechnology | Chairman | |
| Supportive Therapeutics | Chief Executive Officer | ||
Biomica Ltd.
 Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Miscellaneous Commercial Services | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Miscellaneous Commercial Services | Director/Board Member | |
Solbar Food Technologies Ltd.
 Solbar Food Technologies Ltd. Agricultural Commodities/MillingProcess Industries Solbar Food Technologies Ltd. is engaged in soybean production and processing industry. It operates through the following segments: Animal feed, Food products, Refined soybean oil. The company was founded in 1961 and is headquartered in Ashdod, Israel. | Agricultural Commodities/Milling | Director/Board Member | |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Osgoode Hall Law School | College/University | Graduate Degree | |
| St. John's University | College/University | Masters Business Admin | |
| Champlain College | College/University | Undergraduate Degree |
Statistics
International
| Israel | 30 |
| United States | 14 |
| Canada | 8 |
| Netherlands | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 5 |
| Technology Services | 4 |
Operational
| Director/Board Member | 156 |
| Corporate Officer/Principal | 50 |
| Chairman | 34 |
| Independent Dir/Board Member | 33 |
| Undergraduate Degree | 32 |
Most connected contacts
| Insiders | |
|---|---|
| Raf Hofstein | 36 |
| Michael Anghel | 32 |
| Aharon Schwartz | 29 |
| Gil Bianco | 23 |
| Morris Laster | 21 |
| Sandra Panem | 18 |
| Barbara-Jean Bormann-Kennedy | 16 |
| Nurit Benjamini | 15 |
| Kinneret Livnat-Savitsky | 15 |
| Avraham Molcho | 13 |
| Arnon Aharon | 11 |
| Rami Dar | 11 |
| Lior Teitelbaum | 11 |
| David Malek | 11 |
| Philip Serlin | 10 |
- Stock Market
- Insiders
- Mali Zeevi
- Company connections
